Edge Medical-B buys back 4,900 H shares, treasury stock rises to 1.83 million

Bulletin Express07-22

Shenzhen Edge Medical Co., Ltd. (Edge Medical-B) disclosed a Next Day Disclosure Return after repurchasing 4,900 H shares on 22 July 2026 via the Hong Kong Stock Exchange.

The shares were bought at prices ranging from HKD 35.98 to HKD 36.50, translating into a volume-weighted average cost of HKD 36.10 per share and a total cash outlay of approximately HKD 0.18 million. All repurchased shares are being held as treasury stock; none have been cancelled.

Following the transaction, Edge Medical-B’s treasury share balance increased to 1.83 million, while outstanding issued shares (excluding treasury shares) decreased slightly to 325.94 million. Total issued share capital remains unchanged at 327.76 million.

The purchase forms part of the repurchase mandate approved on 25 June 2026, which authorises the company to buy back up to 32.61 million shares. Cumulatively, 209,700 shares—equivalent to 0.064 % of the share base at the mandate date—have been bought under this authority. A moratorium on new share issues or treasury-share sales is in effect until 21 August 2026.

The board confirmed that the repurchase was conducted in full compliance with Hong Kong listing rules and all relevant regulations.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment